The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Mauna Kea Technologies Announces Highlights of Third International Conference of Cellvizio Users (ICCU)

April 11, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

NICE, France, April 11, 2011 /- Mauna Kea Technologies today announced highlights from the 3rd Annual International Conference of Cellvizio® Users (ICCU).  The meeting included 32 different speakers and 25 posters on the role and impact of probe-based confocal laser...


Malpractice Movement Calls for Reporting Directly to Patients, Part 2 in a Series

April 11, 2011 5:34 am | by Diagnostic Imaging | News | Comments

Communication - or failure to communicate - is an important issue in radiology malpractice lawsuits. However, in the past, radiologists have not been the primary communicators of imaging reports with patients, as that has been the responsibility of the referring physician. That is about to change.


PositiveID Corporation Announces Positive Results From Its Easy Check Breath Glucose Detection Device in Preliminary Laboratory Testing

April 11, 2011 5:34 am | by PositiveID | News | Comments

PositiveID Corporation Announces Positive Results From Its Easy Check Breath Glucose Detection Device in Preliminary Laboratory Testing


Researchers find replacement for rare material indium tin oxide

April 11, 2011 3:37 am | by I-Micronews | News | Comments

Researchers at Eindhoven University of Technology have developed a replacement for indium tin oxide (ITO), an important material used in displays for all kinds of everyday products such as TVs, telephones and laptops, as well as in solar cells.

Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX® in EU by Pfizer

April 11, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., April 11, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, today announced that the Company will receive a $30 million regulatory milestone payment from its EU partner, Pfizer Inc. (Pfizer), following the first sale of XIAPEX in...

Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®

April 11, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., April 11, 2011 /- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) announced today that Novartis Pharmaceuticals Corporation, an affiliate of Vanda's sublicensor Novartis Pharma AG, has initiated a clinical study to evaluate the long-acting injectable (or depot) formulation of...


Clinical study suggests estrogen levels and breast health can be altered

April 11, 2011 3:32 am | by EurekAlert | News | Comments

(Strategic Communications) Researchers from Canada and the United States today told attendees of the Experimental Biology 2011 Scientific Meeting that they have uncovered a possible means of enabling women to favorably influence whether the estrogens in their bodies take a "beneficial...


Ligand to Achieve Profitability for 1st Time, Chief Says

April 10, 2011 11:34 pm | by San Diego Business Journal | News | Comments

Ligand Pharmaceuticals Inc. is on track for its first profitable year, said Rob McKay, the biotech's senior director of business development.


ViaCyte Takes Kyoto Laureate's Work to Next Level

April 10, 2011 11:33 pm | by San Diego Business Journal | News | Comments

A San Diego company that is working to bring to market a treatment for diabetes derived from embryonic stem cells is also working with Kyoto Prize winner Shinya Yamanaka


Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710

April 10, 2011 11:33 pm | by Bio-Medicine.Org | News | Comments

WHITEHOUSE STATION, N.J., and VIENNA, April 11, 2011 /- Merck (NYSE: MRK ), known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an...


New review suggests drinking 100 percent fruit juice may offer disease-fighting benefits

April 10, 2011 9:33 pm | by EurekAlert | News | Comments

(Kellen Communications) Highlights from a new report summarizing recent research on the potential benefits of 100 percent fruit juice suggest a positive association between intake of 100 percent juice and reduced risk for several chronic diseases, including cancer, markers for...

Immunization not linked to increased hospitalization for children with inherited disorder

April 10, 2011 9:32 pm | by EurekAlert | News | Comments

(Kaiser Permanente) Children with inborn errors of metabolism received vaccines on the same immunization schedule as did healthy infants, according to Kaiser Permanente Vaccine Study Center scientists who examined the Kaiser Permanente Northern California population. In addition,...


Increased life expectancy discourages religious participation

April 10, 2011 5:37 pm | by EurekAlert | News | Comments

(University of East Anglia) Churches will continue to attract older congregations as increasing life expectancy encourages people to put off involvement in religion, according to new research.

Flu helps spread pneumonia

April 10, 2011 5:32 pm | by EurekAlert | News | Comments

(Society for General Microbiology) Bacteria that cause pneumonia and meningitis are only able to spread when individuals are infected with flu, says a scientist reporting at the Society for General Microbiology's Spring Conference in Harrogate. The work could have implications for the...

Dr. Larissa Shimoda to discuss mechanisms of hypoxic pulmonary hypertension

April 10, 2011 3:33 pm | by EurekAlert | News | Comments

(American Physiological Society) When muscles and organs are deprived of an adequate supply of oxygen, the body's usual responses include increased circulation and slight drop in blood pressure in the blood vessels serving the affected tissue. However, the blood vessels in the lungs react...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.